| Entry |
| ||||||
|---|---|---|---|---|---|---|---|
| Name | Ertapenem sodium (USAN); Invanz (TN) | ||||||
| Product | INVANZ (Merck Sharp & Dohme LLC), ERTAPENEM (Par Pharmaceutical), ERTAPENEM (Par Pharmaceutical) | ||||||
| Generic | ERTAPENEM (AuroMedics Pharma LLC), ERTAPENEM (AuroMedics Pharma LLC), ERTAPENEM SODIUM (Dr.Reddy's Laboratories Inc.,), ERTAPENEM (Hospira), ERTAPENEM SODIUM (NorthStar RxLLC), ERTAPENEM (WG Critical Care), ERTAPENEM (Apotex Corp), ERTAPENEM (BluePoint Laboratories), ERTAPENEM (Fosun Pharma USA), ERTAPENEM (Fresenius Kabi USA), ERTAPENEM (Gland Pharma Limited), ERTAPENEM SODIUM (Hikma Pharmaceuticals USA), ERTAPENEM (Savior Lifetec Corporation) | ||||||
| Formula | C22H24N3O7S. Na | ||||||
| Exact mass | 497.1233 | ||||||
| Mol weight | 497.4966 | ||||||
| Structure |  | ||||||
| Simcomp | |||||||
| Class | Antibacterial DG01710 beta-Lactam antibiotic DG01713 Penicillin skeleton group DG01458 Carbapenem | ||||||
| Remark |
| ||||||
| Efficacy | Antibacterial, Cell wall biosynthesis inhibitor | ||||||
| Target | penicillin binding protein | ||||||
| Pathway |
| ||||||
| Interaction | |||||||
| Brite | Anatomical Therapeutic Chemical (ATC) classification [BR:br08303] J ANTIINFECTIVES FOR SYSTEMIC USE J01 ANTIBACTERIALS FOR SYSTEMIC USE J01D OTHER BETA-LACTAM ANTIBACTERIALS J01DH Carbapenems J01DH03 Ertapenem D04049 Ertapenem sodium (USAN) <US> USP drug classification [BR:br08302] Antibacterials Carbapenems Ertapenem D04049 Ertapenem sodium (USAN) Drug groups [BR:br08330] Antibacterial DG01710 beta-Lactam antibiotic DG01713 Penicillin skeleton group DG01458 Carbapenem DG00592 Ertapenem D04049 Ertapenem sodium Drug classes [BR:br08332] Antibacterial DG01458 Carbapenem D04049 Ertapenem sodium Antimicrobials [BR:br08307] Antibacterials Cell wall biosynthesis inhibitor, beta-lactam Carbapenem D04049 Ertapenem sodium (USAN) <US> New drug approvals in the USA [br08319.html] New molecular entities and new therapeutic biological products D04049 New drug approvals in the USA, Europe and Japan [br08328.html] Approval dates by FDA, EMA and PMDA D04049 Drug groups [BR:br08330] Antibacterial DG01710 beta-Lactam antibiotic DG01713 Penicillin skeleton group DG01458 Carbapenem DG00592 Ertapenem Antimicrobials abbreviations [BR:br08327] Antibacterials Cell wall biosynthesis inhibitor, beta-lactam Carbapenem DG00592 Ertapenem | ||||||
| Other DBs |
| ||||||
| KCF data | ATOM 34 1 C1y C 12.6375 -8.8874 2 C1y C 6.2967 -7.0056 3 C5x C 6.2967 -8.3636 4 N1y N 7.5868 -8.3636 5 C1y C 7.5868 -7.0056 6 C2y C 8.8769 -8.7710 7 C2y C 9.6918 -7.6846 8 C1y C 8.8769 -6.5982 9 C6a C 9.2844 -10.0611 10 O6a O 10.6424 -10.0611 11 O6a O 8.5374 -11.1476 12 S2a S 11.9431 -7.6846 13 C1a C 9.2921 -5.3052 14 C1c C 5.0854 -6.3062 15 C1a C 3.8740 -7.0056 16 O5x O 5.0854 -9.0630 17 O1a O 5.0857 -4.8920 18 C1x C 12.2281 -10.2227 19 N1x N 13.3715 -11.0234 20 C1y C 14.4864 -10.1836 21 C1x C 14.0320 -8.8636 22 C5a C 15.8745 -10.1836 23 O5a O 16.5745 -11.3960 24 C8x C 18.6745 -10.1836 25 C8y C 17.9745 -8.9712 26 N1b N 16.5745 -8.9712 27 C8x C 20.0745 -10.1836 28 C8x C 20.7745 -8.9712 29 C8y C 20.0745 -7.7587 30 C8x C 18.6745 -7.7587 31 C6a C 20.7735 -6.5482 32 O6a O 22.1896 -6.5478 #- 33 O6a O 20.0912 -5.3669 34 Z Na 23.5200 -6.5800 #+ BOND 36 1 2 3 1 2 3 4 1 3 4 5 1 4 2 5 1 5 4 6 1 6 6 7 2 7 7 8 1 8 5 8 1 9 6 9 1 10 9 10 1 11 9 11 2 12 7 12 1 13 8 13 1 #Up 14 2 14 1 15 14 15 1 16 3 16 2 17 14 17 1 #Up 18 1 12 1 #Up 19 1 18 1 20 18 19 1 21 19 20 1 22 20 21 1 23 1 21 1 24 20 22 1 #Up 25 22 23 2 26 24 25 1 27 25 26 1 28 22 26 1 29 24 27 2 30 27 28 1 31 28 29 2 32 29 30 1 33 25 30 2 34 29 31 1 35 31 32 1 36 31 33 2 |